Type 2 diabetes is a disease characterized by high blood sugar levels (hyperglycemia) and occurs when the body is resistant to insulin or does not produce enough. Type 2 diabetes accounts for more than nine out of ten diagnosed cases of diabetes in the US, according to the CDC.
Symptoms of type 2 diabetes may include hunger, thirst, fatigue, increased urination and a tingling sensation in the hands and feet. Obesity is one of the primary causes of type 2 diabetes. Other causal factors include poor eating habits, prediabetes, lack of exercise, and polycystic ovarian syndrome (PCOS). Left untreated, type 2 diabetes can lead to a number of other complications and conditions, such as heart disease, diabetic nephropathy, diabetic neuropathy and ulcers.
Lifestyle changes, such as getting more exercise and eating a healthier diet, are usually recommended to patients with type 2 diabetes. Medication is also prescribed. Drugs used to treat the type 2 diabetes include biguanides, such as metformin, and insulins. Other mediation may include sulfonylureas, gliptins, statins and amyln analogues.
A new authorized generic of Eli Lilly’s insulin drug Humalog (insulin lispro) will soon be available in US pharmacies at half the price of the branded equivalent. The pharmaceutical giant made the announcement on March 4th 2019, asserting that the introduction of an alternative insulin option...
Read MoreLast year saw some significant steps forward in diabetes technology, with a number of new monitoring technologies and insulin delivery devices gaining US Food and Drug Administration (FDA) approval over the course of 2018. Among the new products available to American diabetes patients last year...
Read MoreAfter an indulgent holiday period, you may be one of the many Americans considering setting some 2019 weight loss goals. Losing weight (and goals related to this) are among the most common resolutions for 2019, according to data from YouGov Omnibus. The poll found 48 percent of people planning to...
Read MoreAre you one of the many people in the United States planning to enjoy a smoke-free 2019? A new year comes with the promise of a clean slate and the opportunity to make resolutions to improve your quality of life, leaving you a healthier, stronger and happier person. A YouGov NY poll conducted last...
Read MoreFor parents of children with type 1 diabetes mellitus the diagnosis often comes as a bolt from the blue. There is always a huge amount of information to digest and process and it’s easy to feel overwhelmed by the sudden influx of information on medications, blood glucose testing, dietary...
Read MoreA diabetes diagnosis may seem overwhelming at first, but learning to manage diabetes mellitus enables you to start taking control of your condition, reducing the risk of further diabetes complications and improving your quality of life. Many healthcare professionals can help...
Read MorePatients with type 1 or type 2 diabetes now have a new option for monitoring their glucose levels following the US Food and Drug Administration’s (FDA) decision to approve the first continuous glucose monitoring (CGM) system with a fully implantable sensor. The Eversense CGM can be...
Read MoreSenior patients with diabetes could be more than $350 better off each year if a share of negotiated manufacturer rebates is passed on the patients at the point of sale, according to recent IHS Markit analysis commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA). Passing...
Read MoreThe US Food and Drug Administration (FDA) has permitted marketing of a medical device that utilizes artificial intelligence (AI) to detect certain eye problems related to diabetes. It is the first device of its kind to harness AI to detect diabetic retinopathy considered greater than a mild level...
Read MoreAdult diabetes may fall into five different categories rather than type 1 and type 2 diabetes, according to new research. A study conducted by researchers at Lund University in Sweden found new classifications for diabetes, each with their own distinct genetics and characteristics. It is hoped the...
Read MoreIn an exciting breakthrough for patients with diabetes, the US Food and Drug Administration (FDA) has authorized the marketing of the Dexcom G6 integrated continuous glucose monitoring system (iCGM). The latest version of the continuous glucose monitoring system is indicated for use by patients...
Read MoreObesity and diabetes are significantly more common in the United States than 20 years ago, according to recent data from the National Center for Health Statistics (NCHS). In 1997, under 20 percent of American adults over 20 years of age were classified as obese, a figure that rose to 31.4 percent...
Read MorePatients with health plans with value-based contracts for diabetes, high cholesterol, and HIV medication benefited from significantly cheaper co-pays than patients on other plans, according to new data from the Pharmaceutical Research and Manufacturers of America (PhRMA). On average, these...
Read MoreDiabetes is one of the most prevalent conditions in the United States, with figures from the Centers for Disease Control and Prevention suggesting almost one in ten people live with the condition, the equivalent to 30 million people across the country. The majority of cases - nine out of ten...
Read MorePharmacies in the United States will soon stock two more medications for treating type 2 diabetes after pharmaceutical giants Merck and Pfizer had a pair of products approved by the US Food and Drug Administration (FDA). Steglujan (ertugliflozin and sitagliptin) and Steglatro (ertugliflozin) were...
Read MoreSanofi’s Admelog (insulin lispro injection) is the first short-acting “follow-on” insulin product for diabetes treatment to gain approval from the US Food and Drug Administration (FDA). The rapid-acting insulin is similar to Humalog and is indicated to improve blood sugar control...
Read MoreAdults with type 1 or type 2 diabetes have a new treatment option available to them following the US Food and Drug Administration’s (FDA) decision to approve Novo Nordisk's rapid-acting mealtime insulin Fiasp (insulin aspart). The drug is indicated to improve glycemic control in adults...
Read MoreThe US Food and Drug Administration (FDA) Advisory Committee has voted 16-0 to approve semaglutide as a once-weekly treatment to improve glycemic control in adults with type 2 diabetes. Novo Nordisk submitted the application in December 2016 under the FDA’s Prescription drug user Fee Act...
Read MoreThe US Food and Drug Administration (FDA) has approved the first continuous glucose monitoring system for adult patients with diabetes. The FreeStyle Libre Flash Glucose Monitoring System enables patients to make decisions about their treatment without needing to calibrate using fingerstick...
Read MoreMany medications are available for treating type 2 diabetes, but intensive lifestyle management could hold the key to controlling blood sugar levels, according to a recent clinical trial. The results of the study conducted in Denmark suggest adding "intensive" lifestyle management to traditional...
Read MoreMore than one-third of adults in the US live with either diabetes or prediabetes, a report released by the Centers for Disease Control and Prevention (CDC) has revealed. It found that in 2015 there were 30 million people with diabetes, while a further 84 million people had prediabetes. Left...
Read MorePharmaceutical giant Merck has been granted tentative approval for Lusduna Nexvue (insulin glargine injection) 100 units/mL by the US Food and Drug Administration. The follow-on biologic basal insulin comes in a pre-filled dosing device and will be used to treat patients with type 2...
Read MoreNovo Nordisk has announced a recall of six batches of the insulin cartridge holders used in its NovoPen Echos due to the possibility they will crack or break when exposed to certain chemicals. The company revealed some cleaning agents may contain agents that could leave the device susceptible to...
Read MoreA generic version of the cholesterol-lowering medication Vytorin has been launched by Teva Pharmaceutical Industries, bringing another cheaper statin medication to US pharmacies. Vytorin is an HMG-COA reductase inhibitor/statin with a lipid modifying agent developed by Merck. IMS data from...
Read More
